首页> 外文期刊>Diagnostic microbiology and infectious disease >Azithromycin treatment failure in community-acquired pneumonia caused by Streptococcus pneumoniae resistant to macrolides by a 23S rRNA mutation.
【24h】

Azithromycin treatment failure in community-acquired pneumonia caused by Streptococcus pneumoniae resistant to macrolides by a 23S rRNA mutation.

机译:阿奇霉素在社区获得性肺炎中的治疗失败是由23S rRNA突变对大环内酯类耐药的肺炎链球菌引起的。

获取原文
获取原文并翻译 | 示例
           

摘要

In this report, we describe an azithromycin treatment failure in community-acquired pneumonia. During the first three days of azithromycin, the patient's symptoms worsened, and she was subsequently admitted to the hospital. Blood cultures were positive for a penicillin-susceptible, macrolide-resistant S. pneumoniae. DNA sequencing revealed an A2059G mutation in domain V of the 23S rRNA. To our knowledge, this is the first clinical report of an azithromycin failure in the treatment of S. pneumoniae resistant to macrolides by this mechanism.
机译:在本报告中,我们描述了社区获得性肺炎中阿奇霉素治疗失败的情况。在阿奇霉素的前三天,患者的症状恶化,随后被送往医院。血液培养对青霉素敏感的,对大环内酯类耐药的肺炎链球菌呈阳性。 DNA测序显示23S rRNA的结构域V中存在A2059G突变。据我们所知,这是阿奇霉素通过这种机制治疗对大环内酯类耐药的肺炎链球菌失败的首例临床报道。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号